canyon landscape

LY3154207 in Participants With Dementia due to Lewy Body Dementia

Home / Patient Care / Take Action / Find a Clinical Trial / Clinical Trials / LY3154207 in Participants With Dementia due to Lewy Body Dementia
A randomized placebo-controlled trial to evaluate the safety and efficacy of three doses of study drug LY3154207 treated for 12 weeks in participants with mild-to-moderate dementia associated with LBD (PDD or DLB).
Status
Open and enrolling subjects.
Location
Phoenix, Arizona
Age Range
  • 40-85
Total Participants
340
Keywords
Primary Sponsor
Eli Lilly and Company